LENZ Therapeutics (LENZ) Earnings Date, Estimates & Call Transcripts $23.24 +2.98 (+14.71%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LENZ Therapeutics Earnings Summary Upcoming Earnings DateMay. 14After Market ClosesEstimatedConsensus EPS (Mar. 19) -$0.42 Actual EPS (Mar. 19) -$0.46 Missed By -$0.04 LENZ Therapeutics issued Q4 2024 earnings on March 19, 2025, reporting an EPS of -$0.46, which missed the consensus estimate of -$0.42 by $0.04. With a trailing EPS of -$4.77, LENZ Therapeutics' earnings are expected to decrease next year, from ($2.18) to ($2.58) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K) Slide DeckSEC FilingLENZ Upcoming EarningsLENZ Therapeutics' next earnings date is estimated for Wednesday, May 14, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get LENZ Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LENZ Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLENZ Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Remove Ads LENZ Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.56-$0.52-$0.54Q2 20253-$0.69-$0.60-$0.64Q3 20252-$0.74-$0.73-$0.74Q4 20253-$0.98-$0.66-$0.82FY 202511-$2.97-$2.51-$2.73Q1 20261-$0.92-$0.92-$0.92Q2 20261-$0.77-$0.77-$0.77Q3 20261-$0.67-$0.67-$0.67Q4 20261-$0.53-$0.53-$0.53FY 20264($2.89)($2.89)($2.89) Remove Ads LENZ Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/14/2025(Estimated)--------3/19/2025Q4 2024-$0.42-$0.46 -$0.04-$0.46--11/6/2024Q3 2024-$0.47-$0.38+$0.09-$0.38--8/14/2024Q2 2024-$0.49-$0.40+$0.09-$0.40--5/8/2024Q1 2024-$0.84-$3.53 -$2.69-$3.53--11/13/2023Q3 2023-$0.25-$0.19+$0.06$0.01--8/14/2023Q2 2023-$0.31-$0.31-$0.35--5/11/2023Q1 2023-$0.30-$0.38 -$0.08-$0.33-- LENZ Therapeutics Earnings - Frequently Asked Questions When is LENZ Therapeutics's earnings date? LENZ Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 14th, 2025 based off last year's report dates. Learn more on LENZ's earnings history. Did LENZ Therapeutics beat their earnings estimates last quarter? In the previous quarter, LENZ Therapeutics (NASDAQ:LENZ) missed the analysts' consensus estimate of ($0.42) by $0.04 with a reported earnings per share (EPS) of ($0.46). Learn more on analysts' earnings estimate vs. LENZ's actual earnings. How can I listen to LENZ Therapeutics's earnings conference call? The conference call for LENZ Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read LENZ Therapeutics's conference call transcript? The conference call transcript for LENZ Therapeutics's latest earnings report can be read online. Read Transcript How can I view LENZ Therapeutics's earnings report? LENZ Therapeutics's earnings report can be found in their filing with the SEC. View SEC filing How much profit does LENZ Therapeutics generate each year? LENZ Therapeutics (NASDAQ:LENZ) has a recorded net income of -$124.65 million. LENZ has generated -$4.77 earnings per share over the last four quarters. What is LENZ Therapeutics's EPS forecast for next year? LENZ Therapeutics's earnings are expected to decrease from ($2.18) per share to ($2.58) per share in the next year. More Earnings Resources from MarketBeat Related Companies Mirum Pharmaceuticals Earnings Vericel Earnings Bausch Health Companies Earnings Biohaven Earnings Tarsus Pharmaceuticals Earnings Belite Bio Earnings NewAmsterdam Pharma Earnings Metsera Earnings Arcutis Biotherapeutics Earnings Recursion Pharmaceuticals Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:LENZ) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENZ Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENZ Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LENZ Stock Free LENZ Stock Alerts